Evidence map›Paper›PMID 41399900›Full record

ArticleJournal of experimental botany2025

Dissecting usuranme biquitin-mediated circadian clock regulation in Arabidopsis via high-throughput yeast screens.

Yi-Tsung Tu, Chen-An Chen, Joshua M Gendron, Chin-Mei Lee

Abstract read
In one paragraph

Article in Journal of experimental botany, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yi-Tsung TuInstitute of Plant Biology, National Taiwan University, Taipei, 106319, Taiwan.ORCID 0000-0003-3535-2252
Chen-An ChenInstitute of Plant Biology, National Taiwan University, Taipei, 106319, Taiwan.ORCID 0009-0000-0344-5783
Joshua M GendronMolecular, Cellular and Developmental Biology, Yale University, New Haven, CT, 06511, USA.ORCID 0000-0001-8605-3047
Chin-Mei LeeInstitute of Plant Biology, National Taiwan University, Taipei, 106319, Taiwan.ORCID 0000-0003-3870-4268

Funding

Protein degradation mechanisms that regulate daily and seasonal timingR35GM128670 · NIGMS · YALE UNIVERSITY · PI Joshua Martin Gendron · 2018 to 2026
$4.0M
NIGMS NIH HHS R35 GM128670
6 · The paper itself

Abstract

Protein ubiquitination, mediated by E3 ubiquitin ligases, is a critical regulatory mechanism of eukaryotic cellular processes, including circadian clock function. However, identifying E3-substrate pairs remains technically challenging due to substrate instability and the genetic redundancy of E3s. To overcome these limitations, we developed a high-throughput yeast two-hybrid E3 decoy screening platform, enabling systematic mapping of E3-substrate interactions. Using a library of 283 Arabidopsis F-box and U-box E3 ubiquitin ligases without the domains linking to ubiquitin conjugation, or called E3 decoys, we screened 21 core circadian clock regulators and identified 77 potential E3-substrate interaction pairs involving 56 E3s and 16 clock proteins. Focusing on high-confidence hits, we demonstrated that PLANT U-BOX 18 (PUB18) physically interacts with the central clock regulators LATE ELONGATED HYPOCOTYL (LHY) and JUMONJI DOMAIN-CONTAINING 5 (JMJD5) and promotes their ubiquitination in planta. Genetic analyses further revealed that PUB18 and its homolog PUB19 function redundantly in circadian clock regulation. This study establishes the E3 decoy yeast two-hybrid platform as a versatile and scalable tool for dissecting ubiquitination networks in broad biological processes.

Indexed as

circadian clockE3 ubiquitin ligaseF-box proteinJMJD5LHYPUB18ubiquitinationU-box protein

Identifiers

PMID41399900
PMCPMC13105324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.